Flagship explainer
What drives Ocular Therapeutix, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$266M | FY2025 |
| |
| Income before tax | −$266M | FY2025 |
|
| Operating income | −$270M | FY2025 |
|
| $52M | FY2025 |
| |
| Ending assets | $808M | FY2025 |
|
| Beginning assets | $458M | FY2024 |
|
| $654M | FY2025 |
| |
| $315M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001104659-26-010664